Allarity Therapeutics Files 8-K
Ticker: ALLR · Form: 8-K · Filed: Jul 1, 2025 · CIK: 1860657
Sentiment: neutral
Topics: sec-filing, 8-k
TL;DR
Allarity Therapeutics filed an 8-K on 6/30/25, check for updates.
AI Summary
Allarity Therapeutics, Inc. filed an 8-K on July 1, 2025, reporting events as of June 30, 2025. The filing primarily concerns other events and financial statements/exhibits, with no specific material events detailed in the provided text.
Why It Matters
This 8-K filing indicates that Allarity Therapeutics, Inc. is providing updates to the SEC, which could contain material information for investors.
Risk Assessment
Risk Level: low — The provided text is a standard 8-K filing notification without specific details of material events, making it low risk.
Key Players & Entities
- Allarity Therapeutics, Inc. (company) — Registrant
- June 30, 2025 (date) — Date of earliest event reported
- July 1, 2025 (date) — Filing Date
- Delaware (jurisdiction) — State of incorporation
- 001-41160 (identifier) — SEC File Number
FAQ
What is the primary purpose of this 8-K filing for Allarity Therapeutics, Inc.?
The 8-K filing is a current report pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934, reporting 'Other Events' and 'Financial Statements and Exhibits' as of June 30, 2025.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on June 30, 2025.
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is Allarity Therapeutics, Inc.
In which state was Allarity Therapeutics, Inc. incorporated?
Allarity Therapeutics, Inc. was incorporated in Delaware.
What is the SEC file number for Allarity Therapeutics, Inc.?
The SEC file number for Allarity Therapeutics, Inc. is 001-41160.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 1, 2025 regarding Allarity Therapeutics, Inc. (ALLR).